BioSpace

Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand

A surge of consolidation, rising appetite for specialized manufacturing and a shift toward decentralized trials is reshaping Switzerland’s life sciences landscape. From peptide producers to organoid CROs, service providers are scaling and diversifying as global sponsors turn to Swiss hubs for talent, innovation and regulatory strength.

By BioSpace

1 min read
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights